Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex
Mary Kay Koenig, John M. Slopis(The University of Texas MD Anderson Cancer Center), Cynthia Bell(World Health Organization - Pakistan), Joshua Samuels(AstraZeneca (United Kingdom)), Hope Northrup(The University of Texas MD Anderson Cancer Center), Joan Roberson(The University of Texas Health Science Center at Houston), Adelaide A. Hebert(The University of Texas Health Science Center), Patti L. Pierce Tate(The University of Texas Health Science Center at Houston)
Cited by 96
Related Papers
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|863
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
|Pediatric Neurology|2021|727
Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analyses
|Cell|1991|656
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
|Genetics in Medicine|2014|605